Navigation Links
Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting Stent
Date:7/9/2008

Secondary endpoints of the study include patient compliance with prescribed anti-platelet medication, measures of re-treatment by stenting or surgery, and device and procedural success.

"Post-approval studies allow physicians to follow the safety and efficacy of new treatments in a more complex patient population than is typically studied in pre-approval clinical trials. XIENCE V USA will provide significant insight about the performance of Abbott's new drug eluting stent in a variety of patients," said Charles Simonton, M.D., FACC, FSCAI, divisional vice president, Medical Affairs and chief medical officer, Abbott Vascular. "Our ability to work with our physician partners to begin this post-approval study within days of FDA approval is further evidence of Abbott's commitment to help the interventional cardiology community gain additional insights about the clinical benefits of XIENCE V."

About XIENCE V

XIENCE V is used to treat coronary artery disease by propping open a narrowed or blocked artery and releasing the drug, everolimus, in a controlled manner to prevent the artery from becoming blocked again following a stent procedure. XIENCE V is built upon Abbott's market-leading bare metal stent, the MULTI-LINK VISION(R) Coronary Stent System. The VISION platform is designed to facilitate ease of delivery, making it easier for physicians to maneuver the stent and treat the diseased portion of the artery.

Long-term results with XIENCE V in the SPIRIT III pivotal U.S. clinical trial demonstrated a 45 percent reduction in the risk of major adverse cardiac events (MACE) compared to the TAXUS(R) paclitaxel-eluting coronary stent system at two years. XIENCE V demonstrated a 32 percent reduction in target vessel failure (TVF, cardiac events related to the stented vessel) compared to TAXUS at two years. XIENCE V also demonstrated a low rate of stent thrombosis between one and two years, defined as very late stent thrombosis, per Academic Research
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Abbott Named One of the Best Places to Launch a Career by BusinessWeek
2. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
3. Abbott Scientists Create One Molecule With Two Antibody Functions
4. Abbott Named to Science Magazines List of Top Employers in the Biotech and Pharmaceutical Industry
5. Abbotts HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis
6. Abbott Declares 336th Consecutive Quarterly Dividend
7. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
8. Abbott to Present at JP Morgan Healthcare Conference
9. Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II
10. Isis Announces Equity Investment in Ibis Biosciences Subsidiary by Abbott; Option Acquired to Purchase Remaining Ibis Equity
11. Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... , Sept. 29, 2014 /PRNewswire/ - Portage Biotech Inc. ("Portage" ... is pleased to announce that its three Promissory Note ... who advanced $ 100,000 each in July 2014 for ... Notes and related Coupons converted into 3,500,001 restricted common ... 5% coupon. Both the Note and the coupon were ...
(Date:9/29/2014)... , Sept. 29, 2014 Research and ... Liquid Analyzer, Gas Analyzer, and Gas Chromatograph Market by ... Region - Global Trends & Forecast to 2013 - ... A process analyzer is a process analytical instrument that ... It has redefined the way by which companies carry ...
(Date:9/29/2014)... CA (PRWEB) September 29, 2014 ... at Yale University the 2014 iCELLigence Research Grant ... studies. ACEA’s iCELLigence instrument is an impedance based ... Ph.D. candidate in Department of Biomedical Engineering at ... Fellowship. Chen’s research projects in Professor Rong ...
(Date:9/29/2014)... , Sept. 29, 2014 /PRNewswire/ - SQI Diagnostics ... that develops and commercializes proprietary technologies and products for ... of Peter Winkley to Chairman of the ... .  Mr. Ricks will continue to serve as a ... leadership to the Company.  "We are ...
Breaking Biology Technology:Portage announces conversion of its debt into equity 2Portage announces conversion of its debt into equity 3Global Process Liquid Analyzer, Gas Analyzer, and Gas Chromatograph (PH/ORP, Chlorine, Oxygen, Carbon dioxide) Market - Trends & Forecast to 2020 2Global Process Liquid Analyzer, Gas Analyzer, and Gas Chromatograph (PH/ORP, Chlorine, Oxygen, Carbon dioxide) Market - Trends & Forecast to 2020 3Global Process Liquid Analyzer, Gas Analyzer, and Gas Chromatograph (PH/ORP, Chlorine, Oxygen, Carbon dioxide) Market - Trends & Forecast to 2020 4ACEA Biosciences, Inc. Awards Yale University Researcher the iCELLigence Research Grant 2SQI Diagnostics Announces New Chairman of Board of Directors 2
... Corporation (Portola Valley, CA) filed in Federal District ... TMO ), alleging infringement of Spectros, spectroscopy ... invented and commercialized solid-state, broadband, integrated spectroscopy light ... into its flagship T-Stat product, replacing hot light ...
... term loanST. LOUIS, May 6 2009 First Quarter Highlights , , ... decreased to $339 million from $517 million in the first quarter of 2008 ... million from $95 million in the first quarter of 2008 , ... margins , The Company,s cash generation ...
... May 6 SpectraScience, Inc. (OTC Bulletin ... company, today announced that The Wall Street ... Chief Executive Officer Jim Hitchin. The interview, ... company,s website at http://www.spectrascience.com/tinymce/jscripts/tiny_mce/plugins/ajaxfilemanager/uploaded/Wall%20Street%20Transcript.pdf Mr. ...
Cached Biology Technology:Spectros Corporation Protects Its Cool White LED Spectroscopy Technology Against Alleged Infringement by Thermo Fisher Scientific 2Solutia Reports First Quarter 2009 Results 2Solutia Reports First Quarter 2009 Results 3Solutia Reports First Quarter 2009 Results 4Solutia Reports First Quarter 2009 Results 5Solutia Reports First Quarter 2009 Results 6Solutia Reports First Quarter 2009 Results 7Solutia Reports First Quarter 2009 Results 8Solutia Reports First Quarter 2009 Results 9Solutia Reports First Quarter 2009 Results 10Solutia Reports First Quarter 2009 Results 11Solutia Reports First Quarter 2009 Results 12Solutia Reports First Quarter 2009 Results 13Solutia Reports First Quarter 2009 Results 14Solutia Reports First Quarter 2009 Results 15Solutia Reports First Quarter 2009 Results 16Solutia Reports First Quarter 2009 Results 17Solutia Reports First Quarter 2009 Results 18Solutia Reports First Quarter 2009 Results 19Solutia Reports First Quarter 2009 Results 20Solutia Reports First Quarter 2009 Results 21SpectraScience CEO Jim Hitchin Featured in Interview With The Wall Street Transcript 2SpectraScience CEO Jim Hitchin Featured in Interview With The Wall Street Transcript 3
(Date:9/29/2014)... 2014 -- Plants have a symbiotic relationship with ... extract nutrients and defend against invaders an ... and vegetables. Now, scientist have discovered that plants ... thus ensuring that sprouting plants are colonized from ... Notre Dame, presented their findings today at the ...
(Date:9/29/2014)... to a NASA story from 2009, "human activities in this ... emissions issue. Palm oil is increasingly grown for use as ... in processed foods. It has become the most widely produced ... recent years to surpass that of soybean oil. , The ... to be cleared to grow the crop, and the preferred ...
(Date:9/29/2014)... Parents with children at home should use ventilation when ... University are recommending, after a new study showed an ... symptoms and chronic bronchitis. , "In homes where a ... asthma and wheezing is higher than in homes where ... Smit, an associate professor in the College of Public ...
Breaking Biology News(10 mins):Plants prepackage beneficial microbes in their seeds 2Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 2Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 3
... for superconductivity to branch out and meet some of ... according to a topical review `Superconductivity and the environment: ... journal Superconductor Science and Technology , which explains ... hospitals and address wider issues such as water purification, ...
... and Keshan disease (KD) are major endemic diseases in ... of Professor Xiong Guo from the Institute of Endemic ... of Xi,an Jiaotong University, Key Laboratory of Environment and ... of Trace Elements and Endemic Diseases of Health Ministry, ...
... to buy eco-friendly bamboo apparel are attracted if the ... novelty of the product, according to a new study ... many as friendly to the environment, although the Federal ... some pollutants are released in production from bamboo stalks., ...
Cached Biology News:Superconductivity to meet humanity's greatest challenges 2Superconductivity to meet humanity's greatest challenges 3Several common differentially expressed genes between Kashin-Beck disease and Keshan disease 2Several common differentially expressed genes between Kashin-Beck disease and Keshan disease 3Novelty of eco-friendly bamboo garments lures consumers -- if the price is right, Baylor study shows 2
The piston kit includes 2 pistons to service one F10 pump of a BioLogic DuoFlow workstation....
BD BioCoat Poly-D-Lysine/Laminin 100 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of poly-D-lysine and laminin....
BD BioCoat BD MatrigelTM Matrix 100 mm Culture Dishes for hepatocytes, tissue-culture treated polystyrene with a uniform application of MATRIGEL Matrix....
BD BioCoat Gelatin 100 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of gelatin....
Biology Products: